0002-6145 : Baqsimi 3 mg Nasal Powder


NDC0002-6145
Labeler: Eli Lilly and Company
Product Type: Human Prescription Drug
Drug Name:  Baqsimi
Dosage Form: Nasal Powder
Application #: NDA210134
Rev. Date: 


NDC Package Codes:

  • 0002-6145-11: 1 TUBE IN 1 CARTON (0002‑6145‑11) > 1 BOTTLE, UNIT‑DOSE IN 1 TUBE (0002‑6145‑02) > 1 POWDER IN 1 BOTTLE, UNIT‑DOSE (0002‑6145‑01)
  • 0002-6145-27: 2 TUBE IN 1 CARTON (0002‑6145‑27) > 1 BOTTLE, UNIT‑DOSE IN 1 TUBE (0002‑6145‑02) > 1 POWDER IN 1 BOTTLE, UNIT‑DOSE (0002‑6145‑01)

Active Ingredients:

  • Glucagon

Dosage Strength:

  • 3 mg

Pharmaceutical Classes:

  • Antihypoglycemic Agent [EPC]
  • Gastrointestinal Motility Inhibitor [EPC]
  • Increased Gluconeogenesis [PE]
  • Increased Glycogenolysis [PE]
  • Decreased GI Smooth Muscle Tone [PE]
  • Decreased GI Motility [PE]
  • Decreased Glycolysis [PE]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0002-6145 QR Code

< Prev: 0002-5802Next: 0002-6216 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 17 August 2019.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA